PTH2
Basic information
Region (hg38): 19:49422419-49423441
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PTH2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 16 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 16 | 0 | 0 |
Variants in PTH2
This is a list of pathogenic ClinVar variants found in the PTH2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-49422475-G-A | not specified | Uncertain significance (Jan 23, 2024) | ||
19-49422475-G-T | not specified | Uncertain significance (Oct 26, 2021) | ||
19-49422500-T-G | not specified | Uncertain significance (Oct 12, 2022) | ||
19-49422544-C-A | not specified | Uncertain significance (Nov 30, 2022) | ||
19-49422544-C-G | not specified | Uncertain significance (Jul 19, 2023) | ||
19-49422545-G-A | not specified | Uncertain significance (Nov 15, 2021) | ||
19-49422560-A-G | not specified | Uncertain significance (May 06, 2024) | ||
19-49422571-T-C | not specified | Uncertain significance (Feb 14, 2023) | ||
19-49422596-G-T | not specified | Uncertain significance (Nov 12, 2024) | ||
19-49422622-G-A | not specified | Uncertain significance (Feb 01, 2025) | ||
19-49422625-C-T | not specified | Uncertain significance (Feb 03, 2022) | ||
19-49422632-G-C | not specified | Uncertain significance (Mar 29, 2023) | ||
19-49423222-C-T | not specified | Uncertain significance (Aug 02, 2021) | ||
19-49423227-G-C | not specified | Uncertain significance (Jan 03, 2022) | ||
19-49423236-G-A | not specified | Uncertain significance (Jul 20, 2021) | ||
19-49423264-A-T | not specified | Uncertain significance (Oct 29, 2024) | ||
19-49423267-G-C | not specified | Uncertain significance (Jan 16, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PTH2 | protein_coding | protein_coding | ENST00000270631 | 2 | 1028 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00262 | 0.355 | 124780 | 0 | 27 | 124807 | 0.000108 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.440 | 61 | 52.1 | 1.17 | 0.00000237 | 576 |
Missense in Polyphen | 18 | 15.803 | 1.139 | 162 | ||
Synonymous | 1.37 | 20 | 29.4 | 0.680 | 0.00000134 | 253 |
Loss of Function | -0.963 | 3 | 1.66 | 1.81 | 7.16e-8 | 21 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000290 | 0.0000290 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000256 | 0.000222 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000192 | 0.000164 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role as a potent and selective agonist of PTH2R resulting in adenyl cyclase activation and intracellular calcium levels elevation. Induces protein kinase C beta activation, recruitment of beta-arrestin and PTH2R internalization. May inhibit cell proliferation via its action on PTH2R activation. Neuropeptide which may also have a role in spermatogenesis. May activate nociceptors and nociceptive circuits. {ECO:0000269|PubMed:11861531, ECO:0000269|PubMed:12559132, ECO:0000269|PubMed:12754053, ECO:0000269|PubMed:14988434}.;
- Pathway
- Signaling by GPCR;Signal Transduction;G alpha (s) signalling events;Class B/2 (Secretin family receptors);GPCR ligand binding;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.135
Intolerance Scores
- loftool
- 0.343
- rvis_EVS
- 0.64
- rvis_percentile_EVS
- 83.63
Haploinsufficiency Scores
- pHI
- 0.150
- hipred
- N
- hipred_score
- 0.290
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0591
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pth2
- Phenotype
- reproductive system phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;neuropeptide signaling pathway
- Cellular component
- extracellular region
- Molecular function